AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ARROWHEAD PHARMACEUTICALS, INC. Director's Dealing 2014

Dec 5, 2014

31071_dirs_2014-12-04_0ded1937-c88a-489e-9255-924b9316398d.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2014-12-02

Reporting Person: O'Brien Patrick (General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities beneficially owned.	0	Direct